SIC
TEVA icon

Salem Investment Counselors’s Teva Pharmaceuticals TEVA Stock Holding History

Salem Investment Counselors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509 Buy
+15
New +$500 ﹤0.01% 1187
2019
Q2 		– Sell
-6,275
Closed -$135K – 702
2019
Q1 		$135K Buy
+6,275
New +$111K 0.01% 219
2018
Q4 		– Sell
-6,275
Closed -$135K – 366
2018
Q3 		$135K Buy
6,275
+800
+15% +$18.6K 0.01% 219
2018
Q2 		$133K Sell
5,475
-2,000
-27% -$40.8K 0.01% 218
2018
Q1 		$123K Sell
7,475
-500
-6% -$9.76K 0.01% 217
2017
Q4 		$151K Sell
7,975
-725
-8% -$10.9K 0.02% 211
2017
Q3 		$161K Sell
8,700
-700
-7% -$15.8K 0.02% 206
2017
Q2 		$312K Buy
9,400
+1,068
+13% +$33.1K 0.04% 188
2017
Q1 		$267K Buy
8,332
+32
+0.4% +$1.09K 0.03% 221
2016
Q4 		$301K Buy
8,300
+1,675
+25% +$66.9K 0.03% 215
2016
Q3 		$3.05K Buy
6,625
+575
+10% +$30K 0.04% 188
2016
Q2 		$304K Buy
+6,050
New +$322K 0.04% 218
2016
Q1 		– Sell
-3,263
Closed -$214K – 262
2015
Q4 		$214K Buy
+3,263
New +$202K 0.03% 237
2015
Q3 		– Sell
-3,489
Closed -$206K – 270
2015
Q2 		$206K Buy
3,489
+63
+2% +$3.89K 0.03% 259
2015
Q1 		$213K Buy
+3,426
New +$199K 0.03% 258
2014
Q3 		– Sell
-54,782
Closed -$2.87M – 295
2014
Q2 		$2.87M Sell
54,782
-125
-0.2% -$6.39K 0.35% 79
2014
Q1 		$2.9M Buy
54,907
+1,933
+4% +$89.3K 0.36% 75
2013
Q4 		$2.12M Sell
52,974
-4,550
-8% -$179K 0.28% 90
2013
Q3 		$2.17M Sell
57,524
-40,304
-41% -$1.57M 0.3% 82
2013
Q2 		$3.83M Buy
+97,828
New +$3.81M 0.55% 56

Other funds holding TEVA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return
YDMI
Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Salem Investment Counselors's TEVA Position: Q2 2026 in Review

Salem Investment Counselors opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 15 shares worth $509. The stake represents ﹤0.01% of the portfolio and ranks #1187 among its holdings. This is a return to the name: Salem Investment Counselors previously reported a position in TEVA as recently as Q1 2019.

Salem Investment Counselors first reported a position in TEVA in Q2 2013 and has held it in 20 quarters since. The position peaked at $3.83M in Q2 2013. 293 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Salem Investment Counselors held 15 shares of Teva Pharmaceuticals worth $509 as of Q2 2026.
  • Teva Pharmaceuticals was a new Salem Investment Counselors position in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1187 holding.
  • Salem Investment Counselors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
  • Salem Investment Counselors's Teva Pharmaceuticals position peaked at $3.83M in Q2 2013.
  • 293 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.